Isolate and concentrate are both great sources of protein and contain all nine essential amino acids
Obviously theres new drugs that are coming, new mechanisms, the GLP-1s, GIP, that really is going to continue to evolve and shift the game. The US Food and Drug Administration recently approved the Wegovy GLP-1 oral pill in December 2025
The Short Answer If you are choosing between growth-hormone peptides in 2026, your real decision is between two approaches
If youre concerned about weight loss or severe digestion-related side effects from Rybelsus, talk with your doctor
While possible, they are considered an uncommon symptom, with other side effects like nausea and gastrointestinal discomfort being more prevalent
The Medicare GLP-1 Bridge (launching July 1, 2026, through December 31, 2027) provides weight-loss access to Wegovy at a fixed $50 per month copay outside Part D this does not count toward the deductible, TrOOP, or the $2,100 cap